CYCN
Cyclerion Therapeutics Inc
Halal Rating :
Last Price
$2.93
Last updated:
Market Cap
-
7D Change
-9.29%
1 Year Change
-15.44%
Company Overview
Industries
Exchange
Next Earnings Date
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for serious central nervous system diseases. The company's lead program, CY6463, is being developed for neurological diseases associated with cognitive impairment.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $194000.0 | $1.32m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Cyclerion Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.